UBS Group’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-403,874
Closed -$6.16M 10626
2025
Q4
$6.16M Sell
403,874
-25,047
-6% -$373K ﹤0.01% 3810
2025
Q3
$6.39M Sell
428,921
-16,252
-4% -$236K ﹤0.01% 3785
2025
Q2
$6.38M Sell
445,173
-51,191
-10% -$712K ﹤0.01% 3617
2025
Q1
$7.19M Sell
496,364
-240,321
-33% -$3.62M ﹤0.01% 3403
2024
Q4
$11.1M Sell
736,685
-32,028
-4% -$485K ﹤0.01% 2925
2024
Q3
$11.4M Sell
768,713
-25,793
-3% -$370K ﹤0.01% 2246
2024
Q2
$11.1M Buy
794,506
+9,325
+1% +$131K ﹤0.01% 2127
2024
Q1
$11.5M Buy
785,181
+12,389
+2% +$179K ﹤0.01% 2152
2023
Q4
$10.8M Sell
772,792
-42,697
-5% -$582K ﹤0.01% 2026
2023
Q3
$11.2M Buy
815,489
+17,342
+2% +$245K ﹤0.01% 1904
2023
Q2
$11.3M Buy
798,147
+22,752
+3% +$330K ﹤0.01% 1880
2023
Q1
$11.4M Buy
775,395
+5,142
+0.7% +$78.1K ﹤0.01% 1801
2022
Q4
$11.9M Sell
770,253
-1,938
-0.3% -$29.4K ﹤0.01% 1793
2022
Q3
$10.4M Buy
772,191
+15,606
+2% +$242K ﹤0.01% 1753
2022
Q2
$11.6M Buy
756,585
+37,806
+5% +$605K ﹤0.01% 1703
2022
Q1
$11.9M Buy
718,779
+7,034
+1% +$118K ﹤0.01% 1804
2021
Q4
$12.6M Sell
711,745
-7,188
-1% -$125K ﹤0.01% 1947
2021
Q3
$12M Buy
718,933
+23,508
+3% +$406K ﹤0.01% 1891
2021
Q2
$11.8M Buy
695,425
+39,963
+6% +$672K ﹤0.01% 1895
2021
Q1
$10.7M Sell
655,462
-29,913
-4% -$460K ﹤0.01% 1899
2020
Q4
$10.4M Sell
685,375
-18,186
-3% -$260K ﹤0.01% 1814
2020
Q3
$9.52M Sell
703,561
-17,775
-2% -$245K ﹤0.01% 1677
2020
Q2
$9.82M Sell
721,336
-170,793
-19% -$2.28M ﹤0.01% 1526
2020
Q1
$11.2M Sell
892,129
-150,225
-14% -$2.41M 0.01% 1325
2019
Q4
$18.4M Sell
1,042,354
-28,107
-3% -$500K 0.01% 1442
2019
Q3
$19.1M Buy
1,070,461
+54,508
+5% +$961K 0.01% 1274
2019
Q2
$17.9M Buy
1,015,953
+24,117
+2% +$425K 0.01% 1285
2019
Q1
$17.9M Buy
991,836
+81,414
+9% +$1.43M 0.01% 1209
2018
Q4
$14.7M Sell
910,422
-63,720
-7% -$1.14M 0.01% 1293
2018
Q3
$19.3M Buy
974,142
+162,589
+20% +$3.12M 0.01% 1230
2018
Q2
$15M Buy
811,553
+80,228
+11% +$1.51M 0.01% 1384
2018
Q1
$13M Sell
731,325
-38,495
-5% -$707K 0.01% 1476
2017
Q4
$14.5M Buy
769,820
+24,410
+3% +$436K 0.01% 1419
2017
Q3
$12.6M Sell
745,410
-47,292
-6% -$789K 0.01% 1425
2017
Q2
$13.1M Buy
792,702
+5,322
+0.7% +$86.1K 0.01% 1317
2017
Q1
$12.3M Buy
787,380
+45,533
+6% +$713K 0.01% 1331
2016
Q4
$11.1M Buy
741,847
+179,322
+32% +$2.61M 0.01% 1417
2016
Q3
$8.11M Buy
562,525
+97,240
+21% +$1.42M ﹤0.01% 1597
2016
Q2
$6.76M Buy
465,285
+57,513
+14% +$815K ﹤0.01% 1694
2016
Q1
$5.75M Buy
407,772
+53,132
+15% +$713K ﹤0.01% 1749
2015
Q4
$5.09M Buy
354,640
+50,589
+17% +$721K ﹤0.01% 1948
2015
Q3
$4.1M Sell
304,051
-2,996
-1% -$42.9K ﹤0.01% 2083
2015
Q2
$4.56M Buy
307,047
+18,269
+6% +$277K ﹤0.01% 2172
2015
Q1
$4.38M Buy
288,778
+12,882
+5% +$199K ﹤0.01% 2185
2014
Q4
$4.25M Buy
+275,896
New +$4.44M ﹤0.01% 2237

Other funds holding DIAX

UBS Group's DIAX Position: Q1 2026 in Review

UBS Group sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q1 2026, closing a stake of 403,874 shares — an estimated $6.16M sold.

UBS Group first reported a position in DIAX in Q4 2014 and held it in 45 quarters. The position peaked at $19.3M in Q3 2018. 3 funds tracked by Wall St. Rank hold DIAX as of Q1 2026.

  • UBS Group reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 403,874 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q1 2026, an estimated $6.16M.
  • UBS Group first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q4 2014 and held it in 45 quarters.
  • UBS Group's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $19.3M in Q3 2018.
  • 3 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.